Naru Intelligence one of two companies selected in Roche’s innovation program
Naru Intelligence is one of the companies selected out of a total of 56 companies worldwide to participate in the Roche innovation challenge for hepatocarcinoma patients. Roche has selected Naru Intelligence as one of two companies to participate in its accelerator program, this year focused on hepatocarcinoma patients. Of the